Evidence from research studies and patient-reported data shows that PSC carries a heavy load of visible and invisible symptoms that often begin long before clinical signs appear. While some patients present with disabling symptoms, 40–50% are asymptomatic at first, with PSC discovered incidentally through abnormal liver tests or monitoring for conditions such as inflammatory bowel disease (IBD).
The Most Pervasive and Debilitating Symptoms
Fatigue affects 83–90% of people with PSC and is described as a “crushing”, “whole‑body heaviness” that often starts the moment patients wake up. It brings physical weakness, slowed thinking, and rapid energy collapse, with no relief from rest. Because it doesn’t correlate with liver tests or disease stage, fatigue is difficult to measure or treat, yet it remains one of the highest‑impact symptoms due to its profound effect on daily functioning, work, and social life.
Pruritus affects 40–60% of people with PSC and is often described by patients as a “suicidal itch.” It is unrelenting, sometimes painful, and intensifies at night, leading to severe sleep disruption, skin damage, and significant psychological distress.
Common Clinical Features
Beyond fatigue and itch, there are several other symptoms that are also frequently documented and highly burdensome in PSC patients. Right‑upper‑quadrant or liver pain is reported by 20–40% of adults with PSC. Although the liver itself lacks nerve endings, the capsule surrounding it does, and patients describe both “sharp, stabby” pain and “dull, achy” discomfort that may occur daily rather than only during acute flares.
Cognitive dysfunction — including memory gaps, poor concentration, slowed thinking, and difficulty with verbal fluency — is reported by an estimated 60–80% of patients in patient‑reported outcome studies, and these symptoms significantly impair work, academic performance, and daily functioning.
Episodes of acute bacterial cholangitis occur in 10–20% of patients. Classic indicators include rigors (uncontrollable shivering), high fevers, and intense aching, and these episodes are unpredictable and often require emergency hospitalization for IV antibiotics.
Jaundice is present in 5–10% of patients at diagnosis but becomes more common as PSC progresses, affecting up to 30–40% in advanced disease or during dominant strictures.
Significant unintentional weight loss occurs in 20–30% of patients, often related to advanced disease, fat malabsorption, or active IBD.
Psychological Distress and Uncertainty
Quantitative and qualitative research consistently shows a significant psychological burden among people with PSC. Up to 59% of patients experience clinically significant anxiety or depressive symptoms, driven by fears of mortality, cholangiocarcinoma, and the possibility of requiring a transplant.
A defining feature is uncertainty. Patients describe “living with a huge cloud” or a “bomb” that could go off at any time. This unpredictability makes it difficult to plan for work, family, or social life and contributes heavily to distress.
References
Arndtz, K., Cameron, M., Hirschfield, G., Parry, J., & Greenfield, S. (2025). What are the lived healthcare experiences of patients with primary sclerosing cholangitis? BMJ Open, 15(2), e082498. https://doi.org/10.1136/bmjopen-2023-082498
Gochanour, E., Jayasekera, C., & Kowdley, K. V. (2020). Primary sclerosing cholangitis: Epidemiology, genetics, diagnosis, and current management. Clinical Liver Disease, 15(3), 125–131.
Manns, M. P., Bergquist, A., Karlsen, T. H., Levy, C., Muir, A. J., Ponsioen, C. Y., … & Younossi, Z. M. (2025). Primary sclerosing cholangitis. Nature Reviews Disease Primers, 11, Article 17.
PSC Partners Seeking a Cure. (2022). The voice of the patient: Primary sclerosing cholangitis (PSC). https://pscpartners.org/file_download/inline/2d3c4e91-6970-4af2-b167-eceba5630145
PSC Partners Seeking a Cure. (n.d.). Communicating patient experiences with fatigue, brain fog, and liver pain: The PSC Partners Symptom Assessment Project (SAP). https://pscpartners.org/file_download/inline/a13b08cd-5c99-4e23-9f33-423112f30b1e
Ranieri, V., Kennedy, E., Walmsley, M., Thorburn, D., & McKay, K. (2020). The PSC Wellbeing Study. PLOS ONE, 15(7), e0234624. https://doi.org/10.1371/journal.pone.0234624
